Considering that serous ovarian tumors depicted the lowest levels of E-cadherin among tumor subtypes included in the TMA (Fig 1D and 1E), the occurrence of somatic mutations and the expression of transcriptional E-cadherin repressor factors were evaluated in tumors of this histology. This evidence concerns the gene CDH1 and ovarian serous tumor.